Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

NCT00971620 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Cutaneous Leiomyomas
Hereditary Leiomyomatosis and Renal Cell Cancer

Interventions

BIOLOGICAL: Botulinum toxin type A
OTHER: Placebo

Sponsor

National Cancer Institute (NCI)